| Revenue growth | Value |
|---|---|
| 3Y CAGR | -39% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -67% |
| 3Y CAGR | -14% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Astrazeneca Pharma IndiaASTRAZEN | ₹8,707.00 +137.50 (1.60%) | 21,391.38 | 114.07 | 24.51 | ||
PfizerPFIZER | ₹4,543.80 +80.50 (1.80%) | 20,446.95 | 28.3 | 4.86 | ||
₹1,469.80 +33.20 (2.31%) | 19,867.08 | 30.68 | 5.09 | |||
Granules IndiaGRANULES | ₹795.75 +17.35 (2.23%) | 19,290.99 | 32.42 | 3.79 |